Maintenance Treatment With Low-Dose Mercaptopurine in Combination With Allopurinol in Children With Acute Lymphoblastic Leukemia and Mercaptopurine-Induced Pancreatitis

被引:25
|
作者
Zerra, Patricia [1 ]
Bergsagel, John [1 ]
Keller, Frank G. [1 ]
Lew, Glen [1 ]
Pauly, Melinda [1 ]
机构
[1] Emory Univ, Childrens Healthcare Atlanta, Aflac Canc Ctr & Blood Disorders Serv, Atlanta, GA 30322 USA
关键词
acute lymphoblastic leukemia; allopurinol; mercaptopurine; pancreatitis; 6-MERCAPTOPURINE; TOXICITY; THERAPY; RISK;
D O I
10.1002/pbc.25841
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mercaptopurine (6-mercaptopurine, 6MP) is a mainstay of curative therapy in childhood acute lymphoblastic leukemia (ALL), and contributes to its 90% overall survival rate. We present two patients with ALL who suffered with severe pancreatitis secondary to 6MP. Through the use of allopurinol in conjunction with reduced dose 6MP, we were able to continue 6MP without further pancreatitis. This report contributes to the small body of literature on 6MP associated pancreatitis in childhood ALL and describes a novel approach to continued use of 6MP during therapy.
引用
收藏
页码:712 / 715
页数:4
相关论文
共 50 条
  • [11] Mercaptopurine-induced hypersensitivity febrile reaction in patient with acute promyelocytic leukemia
    Neokleous, Nikolaos
    Seimeni, Ourania
    Koumas, Sotirios
    Prokopiou, Chrystalla
    LEUKEMIA & LYMPHOMA, 2012, 53 (03) : 495 - 496
  • [12] Allopurinol Use During Maintenance Therapy for Acute Lymphoblastic Leukemia Avoids Mercaptopurine-related Hepatotoxicity
    Giamanco, Nicole M.
    Cunningham, Bethany S.
    Klein, Laura S.
    Parekh, Dina S.
    Warwick, Anne B.
    Lieuw, Kenneth
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (02) : 147 - 151
  • [13] Skin Toxicity Due to Mercaptopurine in Maintenance Therapy Among Children With Acute Lymphoblastic Leukemia
    Higgerson, Kayeleigh
    Flatt, Terrie
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2023, 45 (04) : E514 - E517
  • [14] An exploration of mercaptopurine/methotrexate tolerance during maintenance therapy in children with acute lymphoblastic leukemia
    Whiley, A. C.
    Price, V
    MacDonald, T.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) : 1631 - 1636
  • [15] The frequency of NUDT15 rs116855232 and its impact on mercaptopurine-induced toxicity in Syrian children with acute lymphoblastic leukemia
    Muhammad, Muhammad
    Saifo, Maher
    Aljamali, Majd
    Alali, Mousa
    Ghanem, Khaled M.
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [16] Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy
    de Beaumais, Tiphaine Adam
    Fakhoury, May
    Medard, Yves
    Azougagh, Said
    Zhang, Daolun
    Yakouben, Karima
    Jacqz-Aigrain, Evelyne
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (04) : 575 - 584
  • [17] Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia
    Tiphaine Adam de Beaumais
    Evelyne Jacqz-Aigrain
    European Journal of Clinical Pharmacology, 2012, 68 : 1233 - 1242
  • [18] Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia
    de Beaumais, Tiphaine Adam
    Jacqz-Aigrain, Evelyne
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (09) : 1233 - 1242
  • [19] MERCAPTOPURINE VS THIOGUANINE FOR THE TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA
    EVANS, WE
    RELLING, MV
    LEUKEMIA RESEARCH, 1994, 18 (11) : 811 - 814
  • [20] USE OF ALLOPURINOL TO REDIRECT 6-MERCAPTOPURINE METABOLISM IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    Stuckert, Austin
    Schafer, Eric
    Bernhardt, M. Brooke
    Baxter, Patricia
    Brackett, Julienne
    PEDIATRIC BLOOD & CANCER, 2018, 65